References
- Cho A.K., Lindeke B, Sum C.Y. Drug Metab. Disp. 1974; 2: 1
- Dahlbom R., Karlén B., George R, Jenden D.J. Life Sci. 1966; 5: 1625
- Daly J. Handbuch der Experimentellen Pharmakologie, O Von Eichler. Springer Verlag, Berlin 1972; vol. 28: 286, II
- Diehl E., Najm S., Wolff R.E., Ehrhardt J.D. J. Pharmac. 1976; 7: 563
- Djerassi C, Lenk C.T. J. Am. chem. Soc. 1953; 75: 3493
- Geiger P.J., Bessman S.P. Analyt. Biochem. 1972; 49: 467
- Gross H. J. Prakt. Chem. 1963; 21: 99
- Jones E.R.H., Skatteböl L, Whiting M.C. J. chem. Soc. 1956; 4765
- Karlén B, Bogentoft C. Acta Pharm. Suec. 1969; 6: 543
- Karlén B., Lindeke B., Lindgren S., Svensson K.-G., Dahlbom R., Jenden D.J., Giering J.E. J. Med. Chem. 1970; 13: 651
- Lespieau R. Bull. Soc. Chim. France 1926; 39: 991
- Lespieau R. Bull. Soc. Chim. France 1928; 43: 199
- Lindeke B. Satellite Symposium on oxotremorine antagonists as anti-parkinsonian agents. 6th Int. Pharm. Congr. 1975
- Lindeke B., Hallström G., Anderson E, Karlén B. Xenobiotica 1977; 7: 95
- Lindgren S., Lindquist Å., Lindeke B., Svensson U., Karlén B., Dahlbom R, Blair M. R., Jr. Acta Pharm. Suec. 1973; 10: 435
- Lindquist Å., Lindgren S., Lindeke B., Karlén B., Dahlbom R, Blair M. R., Jr. Acta Pharm. Suec. 1972; 9: 93
- Parli C.J., Mannering G.J. Biochem. Pharmac. 1971; 20: 2118
- Reich J, Seeger U. Arch. Pharm. 1977; 310: 888, (weinheim)
- Schenkman J.B., Ball J.A., Estabrook R.W. Biochem. Pharmac. 1967; 16: 1071
- Schulte K.E., Rücker G. Drug Research, E Jucker. Birkhäuser Verlag, and references therein, Basel-Stuttgart 1970; vol. 14: 387
- Svensson U, Dahlbom R. Acta Pharm. Suec. 1975; 12: 209
- Welles J.R., McMahon R.E., Poran W.J. J. Pharmac. exp. Ther. 1963; 139: 166